إعلان
إعلان
SNDX
Syndax Pharmaceuticals, Inc.
21.00
USDبرعاية
-0.38
-1.78%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
21.04
+0.04
+0.17%
تقارير أرباح SNDX
النسبة الإيجابية المفاجئة
SNDX تفوق 29 من 39 آخر التقديرات.
74%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$65.38M
/-$0.60
التغير الضمني من Q3 25 (Revenue/ EPS)
+42.54%
/-14.29%
التغير الضمني من Q4 24 (Revenue/ EPS)
+751.34%
/-45.45%
Syndax Pharmaceuticals, Inc. earnings per share and revenue
On ٠٣ نوفمبر ٢٠٢٥, SNDX reported earnings of -0.70 USD per share (EPS) for Q3 25, beating the estimate of -0.73 USD, resulting in a 4.24% surprise. Revenue reached 45.87 مليون, compared to an expected 48.94 مليون, with a -6.26% difference. The market reacted with a +11.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 المحللين forecast an EPS of -0.60 USD, with revenue projected to reach 65.38 مليون USD, implying an نقصان of -14.29% EPS, and زيادة of 42.54% in Revenue from the last quarter.
الأسئلة الشائعة
What were Syndax Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Syndax Pharmaceuticals, Inc. reported EPS of -$0.70, beating estimates by 4.24%, and revenue of $45.87M, -6.26% below expectations.
How did the market react to Syndax Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 11.56%, changed from $13.76 before the earnings release to $15.35 the day after.
When is Syndax Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for Syndax Pharmaceuticals, Inc.'s next earnings report?
Based on 16
المحللين, Syndax Pharmaceuticals, Inc. is expected to report EPS of -$0.60 and revenue of $65.38M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان